Astragalus

    Researchedby:

    Fact-checked

    by:

    Last Updated: August 1, 2024

    Astragalus membranaceus is an herb used in Traditional Chinese Medicine. It is claimed to have anti-inflammatory, cardioprotective, and anti-aging effects.

    What is astragalus?

    Various Astragalus species are used in alternative medicine around the world.[1][2] This page refers to Astragalus membranaceus, a popular herb used in Traditional Chinese Medicine, also known as Astragali radix or huangqi.[3][4] Astragalus membranaceus can be used alone, but it is also paired with another herb called Angelicae sinensis in Danggui Buxue Tang, a Chinese medicine.[5] Astragalus membranaceus contains several bioactive compounds, including polysaccharides, flavonoids, and saponins. Its major bioactive molecules include calycosin, formononetin, cycloastragenol, and astragaloside IV,[6][7] and another of its bioactive molecules has been patented under the name TA-65 (telomerase activator 65).[8]

    What are astragalus’s main benefits?

    There are widespread claims about the beneficial effects of Astragalus membranaceus and its bioactive molecules on several conditions. These include chronic heart failure,[9][10] metabolic syndrome,[11] blood lipids,[12] diabetes,[13][14][15][16] kidney disease,[17][18][19][20][15][16] neurological disorders,[21] cell lifespan,[3][8] and cancer.[22][23][24][25] However, the quality of evidence for these effects in humans is generally low because of variable findings between studies, poor methodological quality, unclear methodological details, widespread lack of blinding, use of intravenous rather than oral administration, and publication bias in favor of predominantly positive findings being published.[9][10][17][18][19][20][12][13][14][22][23][24][25] Furthermore, much of the evidence supporting the benefits of astragaloside IV is derived from animal and cell-culture experiments,[26][15][16][27][21][28] while clinical studies showing the therapeutic benefit of TA-65 are authored by the group that patented the compound.[8][11] Consequently, high-quality randomized controlled trials by independent researchers are urgently needed to confirm these therapeutic claims.

    What are astragalus’s main drawbacks?

    There is no obvious toxicity nor serious side effects caused by Astragalus membranaceus or its bioactive molecules.[29][30][31][32][8][9][10] However, human studies often fail to record the side effects of astragalus.[17][33][32][9][10][20]

    The main drawback is that research in this field has major limitations. For example, systematic reviews conclude that evidence in this field is generally of low quality.[9][10][17][18][19][20][12][13][14][22][23][24][25] Furthermore, it is often unclear which species (e.g., Astragalus membranaceus) or part (entire plant, roots, flowers, etc.) of an Astragalus plant is used or which type of extract is administered (i.e., a purified bioactive molecule or a collection of molecules). Additionally, astragalus supplements/extracts are often combined with other compounds or drugs, so their direct effects cannot always be determined. These limitations reduce the certainty of the claimed benefits.

    How does astragalus work?

    Pharmacological research indicates that Astragalus membranaceus[3][34][35][36] and its bioactive molecules (e.g., calycosin, formononetin, cycloastragenol, astragaloside IV,[37][38][6][7] and TA-65[39][40][37][8]) can regulate several pathways, including antioxidant, anti-inflammatory, and immunological systems, as well as increase telomerase activity, which prolongs the lifespan of cells. This may explain the potential role of astragalus in the treatment of chronic disease. However, most of the pharmacological evidence is derived from cell-culture (i.e., in vitro) and animal experiments.[26][15][16][27][21][28] Further clinical pharmacology research is needed to fully understand the potential mechanism(s) of action in humans.

    What are other names for Astragalus

    Note that Astragalus is also known as:
    • Astragalus
    • huangqi
    • (A Component Of) Danggui Buxue Tang (DBT)
    • Membranous Milk-vetch Root
    • Ogi
    • Huang Qi
    • TA-65
    • TAT2
    • Astragalus Membranaceus
    Astragalus should not be confused with:

    Dosage information

    Astragalus membranaceus and Angelicae sinensis are highly synergistic, meaning they are more powerful when taken together. This combination is traditionally called Dang-gui buxue tang.

    The starting point for the preparation of Dang-gui buxue tang in traditional Chinese medicine is 30 grams of Astragalus membranaceus root paired with 6 grams of Angelicae sinensis. This is a 5:1 ratio, which is ideal for extracting the bioactive ingredients of the plants.

    Astragalus membranaceus can also be supplemented via a root extract. Due to potential differences in the quality/efficiency of the extraction process among different commercial manufacturers, product label recommendations for dosage should be followed and you should consult with your pharmacist or personal physician before taking.

    The main bioactive compound in Astragalus membranaceus is astragaloside IV, which can be supplemented by itself. The standard dose for astragaloside IV is 5–10 mg.

    Frequently asked questions

    What is astragalus?

    Various Astragalus species are used in alternative medicine around the world.[1][2] This page refers to Astragalus membranaceus, a popular herb used in Traditional Chinese Medicine, also known as Astragali radix or huangqi.[3][4] Astragalus membranaceus can be used alone, but it is also paired with another herb called Angelicae sinensis in Danggui Buxue Tang, a Chinese medicine.[5] Astragalus membranaceus contains several bioactive compounds, including polysaccharides, flavonoids, and saponins. Its major bioactive molecules include calycosin, formononetin, cycloastragenol, and astragaloside IV,[6][7] and another of its bioactive molecules has been patented under the name TA-65 (telomerase activator 65).[8]

    What are astragalus’s main benefits?

    There are widespread claims about the beneficial effects of Astragalus membranaceus and its bioactive molecules on several conditions. These include chronic heart failure,[9][10] metabolic syndrome,[11] blood lipids,[12] diabetes,[13][14][15][16] kidney disease,[17][18][19][20][15][16] neurological disorders,[21] cell lifespan,[3][8] and cancer.[22][23][24][25] However, the quality of evidence for these effects in humans is generally low because of variable findings between studies, poor methodological quality, unclear methodological details, widespread lack of blinding, use of intravenous rather than oral administration, and publication bias in favor of predominantly positive findings being published.[9][10][17][18][19][20][12][13][14][22][23][24][25] Furthermore, much of the evidence supporting the benefits of astragaloside IV is derived from animal and cell-culture experiments,[26][15][16][27][21][28] while clinical studies showing the therapeutic benefit of TA-65 are authored by the group that patented the compound.[8][11] Consequently, high-quality randomized controlled trials by independent researchers are urgently needed to confirm these therapeutic claims.

    What are astragalus’s main drawbacks?

    There is no obvious toxicity nor serious side effects caused by Astragalus membranaceus or its bioactive molecules.[29][30][31][32][8][9][10] However, human studies often fail to record the side effects of astragalus.[17][33][32][9][10][20]

    The main drawback is that research in this field has major limitations. For example, systematic reviews conclude that evidence in this field is generally of low quality.[9][10][17][18][19][20][12][13][14][22][23][24][25] Furthermore, it is often unclear which species (e.g., Astragalus membranaceus) or part (entire plant, roots, flowers, etc.) of an Astragalus plant is used or which type of extract is administered (i.e., a purified bioactive molecule or a collection of molecules). Additionally, astragalus supplements/extracts are often combined with other compounds or drugs, so their direct effects cannot always be determined. These limitations reduce the certainty of the claimed benefits.

    How does astragalus work?

    Pharmacological research indicates that Astragalus membranaceus[3][34][35][36] and its bioactive molecules (e.g., calycosin, formononetin, cycloastragenol, astragaloside IV,[37][38][6][7] and TA-65[39][40][37][8]) can regulate several pathways, including antioxidant, anti-inflammatory, and immunological systems, as well as increase telomerase activity, which prolongs the lifespan of cells. This may explain the potential role of astragalus in the treatment of chronic disease. However, most of the pharmacological evidence is derived from cell-culture (i.e., in vitro) and animal experiments.[26][15][16][27][21][28] Further clinical pharmacology research is needed to fully understand the potential mechanism(s) of action in humans.

    Update History

    Research Breakdown

    References

    1. ^Amiri MS, Joharchi MR, Nadaf M, Nasseh YEthnobotanical knowledge of spp.: The world's largest genus of vascular plants.Avicenna J Phytomed.(2020)
    2. ^Salehi B, Carneiro JNP, Rocha JE, Coutinho HDM, Morais Braga MFB, Sharifi-Rad J, Semwal P, Painuli S, Moujir LM, de Zarate Machado V, Janakiram S, Anil Kumar NV, Martorell M, Cruz-Martins N, El Beyrouthy M, Sadaka CAstragalus species: Insights on its chemical composition toward pharmacological applications.Phytother Res.(2020-Dec-16)
    3. ^Liu P, Zhao H, Luo YAnti-Aging Implications of (Huangqi): A Well-Known Chinese Tonic.Aging Dis.(2017-Dec)
    4. ^Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, Zhang H, Yang SReview of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi).Phytother Res.(2014-Sep)
    5. ^Kwan KKL, Huang Y, Leung KW, Dong TTX, Tsim KWKDanggui Buxue Tang, a Chinese Herbal Decoction Containing Astragali Radix and Angelicae Sinensis Radix, Modulates Mitochondrial Bioenergetics in Cultured Cardiomyoblasts.Front Pharmacol.(2019)
    6. ^Zhang J, Wu C, Gao L, Du G, Qin XAstragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.Adv Pharmacol.(2020)
    7. ^Gu Y, Wang G, Pan G, Fawcett JP, A J, Sun JTransport and bioavailability studies of astragaloside IV, an active ingredient in Radix Astragali.Basic Clin Pharmacol Toxicol.(2004-Dec)
    8. ^Harley CB, Liu W, Blasco M, Vera E, Andrews WH, Briggs LA, Raffaele JMA natural product telomerase activator as part of a health maintenance program.Rejuvenation Res.(2011-Feb)
    9. ^Fu S, Zhang J, Menniti-Ippolito F, Gao X, Galeotti F, Massari M, Hu L, Zhang B, Ferrelli R, Fauci A, Firenzuoli F, Shang H, Guerra R, Raschetti RHuangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.PLoS One.(2011-May-06)
    10. ^Wang K, Wu J, Duan X, Wu J, Zhang D, Zhang X, Zhang BHuangqi injection in the treatment of chronic heart failure: A systematic review and meta-analysis.Medicine (Baltimore).(2017-Sep)
    11. ^Fernandez ML, Thomas MS, Lemos BS, DiMarco DM, Missimer A, Melough M, Chun OK, Murillo AG, Alyousef HM, Medina-Vera ITA-65, A Telomerase Activator improves Cardiovascular Markers in Patients with Metabolic Syndrome.Curr Pharm Des.(2018)
    12. ^Yu L, Zhou C, Luo Z, Zeng W, Lai F, Han G, Song YThe lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials.Lipids Health Dis.(2018-May-10)
    13. ^Tian H, Lu J, He H, Zhang L, Dong Y, Yao H, Feng W, Wang SThe effect of Astragalus as an adjuvant treatment in type 2 diabetes mellitus: A (preliminary) meta-analysis.J Ethnopharmacol.(2016-Sep-15)
    14. ^Zhang K, Pugliese M, Pugliese A, Passantino ABiological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes: a systematic review.Mini Rev Med Chem.(2015)
    15. ^Zhou XT, Zou JJ, Ao C, Gong DY, Chen X, Ma YRRenal protective effects of astragaloside IV, in diabetes mellitus kidney damage animal models: A systematic review, meta-analysis.Pharmacol Res.(2020-Oct)
    16. ^Wang H, Zhuang Z, Huang YY, Zhuang ZZ, Jin Y, Ye HY, Lin XJ, Zheng Q, Wang YLProtective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis.Front Pharmacol.(2020)
    17. ^Hong Wei Zhang, Zhi Xiu Lin, Chuanshan Xu, Connie Leung, Lai Sum ChanAstragalus (a traditional Chinese medicine) for treating chronic kidney diseaseCochrane Database Syst Rev.(2014 Oct 22)
    18. ^Feng M, Yuan W, Zhang R, Fu P, Wu TChinese herbal medicine Huangqi type formulations for nephrotic syndrome.Cochrane Database Syst Rev.(2013-Jun-05)
    19. ^Zhang L, Shergis JL, Yang L, Zhang AL, Guo X, Zhang L, Zhou S, Zeng L, Mao W, Xue CCAstragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis.J Ethnopharmacol.(2019-Jul-15)
    20. ^ZhongChi Xu, LiChao Qian, RuGe Niu, Ying Yang, ChunLing Liu, Xin LinEfficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-AnalysisFront Med (Lausanne).(2022 Apr 25)
    21. ^Ianara M Costa, Francisca O V Lima, Luciana C B Fernandes, Bianca Norrara, Francisca I Neta, Rodrigo D Alves, José R L P Cavalcanti, Eudes E S Lucena, Jeferson S Cavalcante, Amalia C M Rego, Irami A Filho, Dinalva B Queiroz, Marco A M Freire, Fausto P GuzenAstragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic ReviewCurr Neuropharmacol.(2019)
    22. ^Cheng M, Hu J, Zhao Y, Jiang J, Qi R, Chen S, Li Y, Zheng H, Liu R, Guo Q, Zhang X, Qin Y, Hua BEfficacy and Safety of -Containing Traditional Chinese Medicine Combined With Platinum-Based Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.Front Oncol.(2021)
    23. ^Shen L, Gwak SR, Cui ZY, Joo JC, Park SJAstragalus-Containing Chinese Herbal Medicine Combined With Chemotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis.Front Pharmacol.(2021)
    24. ^Lin S, An X, Guo Y, Gu J, Xie T, Wu Q, Sui XMeta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response.Front Oncol.(2019)
    25. ^Cao A, He H, Wang Q, Li L, An Y, Zhou XEvidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis.Medicine (Baltimore).(2019-Mar)
    26. ^Han Z, Zhu J, Han ZEvaluation of astragaloside IV in hepatic fibrosis: A meta-analysis.Medicine (Baltimore).(2021-Apr-02)
    27. ^Zhuang Z, Wang ZH, Deng LH, Zheng Q, Zheng GQ, Wang YAstragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis.Front Pharmacol.(2019)
    28. ^Zheng Q, Zhu JZ, Bao XY, Zhu PC, Tong Q, Huang YY, Zhang QH, Zhang KJ, Zheng GQ, Wang YA Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury.Front Physiol.(2018)
    29. ^Song J, Lee D, Min B, Bae JS, Chang GT, Kim HSafety evaluation of Astragalus extract mixture HT042 and its constituent herbs in Sprague-Dawley rats.Phytomedicine.(2017-Aug-15)
    30. ^Murbach TS, Glávits R, Endres JR, Hirka G, Vértesi A, Béres E, Szakonyiné IPToxicological Evaluation of a Mixture of and Root Extracts (InnoSlim®).J Toxicol.(2019)
    31. ^Harley CB, Liu W, Flom PL, Raffaele JMA natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response.Rejuvenation Res.(2013-Oct)
    32. ^Wang C, Xia Q, Hu B, Jiang W, Zhang HThe Effectiveness and Safety of Huangqi Xixin Decoction for Cough Variant Asthma: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med.(2022)
    33. ^Su G, Chen X, Liu Z, Yang L, Zhang L, Stålsby Lundborg C, Wen Z, Guo X, Qin X, Liang J, Liu XOral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.Cochrane Database Syst Rev.(2016-Dec-01)
    34. ^Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu YA Review of the Pharmacological Action of Astragalus Polysaccharide.Front Pharmacol.(2020)
    35. ^Man Li, Bing Han, Huan Zhao, Chongyi Xu, Daokun Xu, Elwira Sieniawska, Xianming Lin, Guoyin KaiBiological active ingredients of Astragali Radix and its mechanisms in treating cardiovascular and cerebrovascular diseasesPhytomedicine.(2022 Jan 8)
    36. ^Abd Elrahim Abd Elkader HT, Essawy AE, Al-Shami ASAstragalus species: Phytochemistry, biological actions and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases.Phytochemistry.(2022-Oct)
    37. ^Bernardes de Jesus B, Schneeberger K, Vera E, Tejera A, Harley CB, Blasco MAThe telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence.Aging Cell.(2011-Aug)
    38. ^Yang Y, Hong M, Lian WW, Chen ZReview of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation.World J Clin Cases.(2022-Oct-06)
    39. ^Salvador L, Singaravelu G, Harley CB, Flom P, Suram A, Raffaele JMA Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study.Rejuvenation Res.(2016-Dec)
    40. ^Molgora B, Bateman R, Sweeney G, Finger D, Dimler T, Effros RB, Valenzuela HFFunctional assessment of pharmacological telomerase activators in human T cells.Cells.(2013-Jan-14)